Skip to content
Back to Guavy Wire
Stocks

Johnson & Johnson Exec Sells Stock Options Worth Over $3.9 Million

Instruments
JNJ
Share

Jennifer Taubert, Executive Vice President and Worldwide Chairman of Innovative Medicine at Johnson & Johnson (NYSE:JNJ), made significant stock transactions on August 17, 2026.

Taubert exercised employee stock options to acquire 15,000 shares of common stock with an exercise price of $115.67 per share, totaling $1,735,050.

She then sold the same number of shares at a weighted average price of $263.36, generating approximately $3.95 million from the sale.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc